Gunilla Lundmark

Gunilla Lundmark is a seasoned professional with extensive experience in leadership and board roles across various organizations. Currently serving as a Board Member at SampleFacts and CombiGene, Gunilla Lundmark is also the CEO of Uppsala universitet Invest AB, which focuses on commercializing research from Uppsala University, and holds board positions at Lipidor AB, UIC - Uppsala Innovation Centre, and Chordate Medical Holding AB. With a strong background in business and innovation, Gunilla Lundmark has held leadership roles in multiple enterprises, including serving as Chairman of the Board at Strike Pharma AB and participating in various boards such as IPF and Innovationsstiftelsen vid Handelsbanken Uppsala City. Gunilla Lundmark holds an Executive MBA and a Bachelor of Science degree from Uppsala University.